CN102824406B - 龙丹通络胶囊在制备抑制mj细胞增殖药物中的应用 - Google Patents
龙丹通络胶囊在制备抑制mj细胞增殖药物中的应用 Download PDFInfo
- Publication number
- CN102824406B CN102824406B CN201210358129.0A CN201210358129A CN102824406B CN 102824406 B CN102824406 B CN 102824406B CN 201210358129 A CN201210358129 A CN 201210358129A CN 102824406 B CN102824406 B CN 102824406B
- Authority
- CN
- China
- Prior art keywords
- cell proliferation
- collateral vessels
- red capsule
- dragon
- freeing collateral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 17
- 230000004663 cell proliferation Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- QGAYMQGSQUXCQO-UHFFFAOYSA-L eosin b Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC([N+]([O-])=O)=C([O-])C(Br)=C1OC1=C2C=C([N+]([O-])=O)C([O-])=C1Br QGAYMQGSQUXCQO-UHFFFAOYSA-L 0.000 claims abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 4
- 230000001629 suppression Effects 0.000 abstract description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract description 2
- 241000237903 Hirudo Species 0.000 abstract description 2
- 239000009636 Huang Qi Substances 0.000 abstract description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract description 2
- 241000972155 Moschus Species 0.000 abstract description 2
- 241000237636 Pheretima Species 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 208000011580 syndromic disease Diseases 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 8
- 206010025323 Lymphomas Diseases 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 208000017604 Hodgkin disease Diseases 0.000 description 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- QZKDXSOKZHLFHE-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(OCO2)C2=C1 QZKDXSOKZHLFHE-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210358129.0A CN102824406B (zh) | 2012-09-24 | 2012-09-24 | 龙丹通络胶囊在制备抑制mj细胞增殖药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210358129.0A CN102824406B (zh) | 2012-09-24 | 2012-09-24 | 龙丹通络胶囊在制备抑制mj细胞增殖药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102824406A CN102824406A (zh) | 2012-12-19 |
CN102824406B true CN102824406B (zh) | 2016-01-27 |
Family
ID=47327852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210358129.0A Active CN102824406B (zh) | 2012-09-24 | 2012-09-24 | 龙丹通络胶囊在制备抑制mj细胞增殖药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102824406B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105943701B (zh) * | 2016-06-23 | 2020-12-01 | 上海医药集团青岛国风药业股份有限公司 | 益气活血药物在制备失眠药物中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1943620A (zh) * | 2005-10-08 | 2007-04-11 | 周小明 | 一种治疗心脑血管疾病的中药组合物及其制备方法 |
CN101129464A (zh) * | 2007-08-21 | 2008-02-27 | 高翔 | 一种益气活血、祛瘀通脉的中药组合物及其制备方法 |
-
2012
- 2012-09-24 CN CN201210358129.0A patent/CN102824406B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1943620A (zh) * | 2005-10-08 | 2007-04-11 | 周小明 | 一种治疗心脑血管疾病的中药组合物及其制备方法 |
CN101129464A (zh) * | 2007-08-21 | 2008-02-27 | 高翔 | 一种益气活血、祛瘀通脉的中药组合物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
恶性淋巴瘤从痰瘀论治的体会;陈琰碧等;《中医杂志》;19961231(第9期);524 * |
Also Published As
Publication number | Publication date |
---|---|
CN102824406A (zh) | 2012-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103784738B (zh) | 一种含玛咖的植物组合物提取方法和应用 | |
CN103860802B (zh) | 一种接骨七厘片的制备方法及应用 | |
CN102824406B (zh) | 龙丹通络胶囊在制备抑制mj细胞增殖药物中的应用 | |
CN105030868A (zh) | 一种含水飞蓟的植物组合物提取方法和应用 | |
CN103690601B (zh) | 一种健心片的应用及制备方法 | |
CN103690756B (zh) | 一种清肺抑火片的应用及制备方法 | |
CN102824614A (zh) | 乌金片在制备抑制pc-3细胞增殖药物中的应用 | |
CN105055805A (zh) | 一种含穿心莲的植物组合物提取方法和应用 | |
CN102824515B (zh) | 热毒清片在制备抑制a-204细胞增殖药物中的应用 | |
CN102836261B (zh) | 强龙益肾胶囊在制备抑制mda-mb-157细胞增殖药物中的应用 | |
CN103656415B (zh) | 一种咽炎片的应用及制备方法 | |
CN102824517B (zh) | 缩泉胶囊在制备抑制os-732细胞增殖药物中的应用 | |
CN102836215B (zh) | 香菊胶囊在制备抑制a875细胞增殖药物中的应用 | |
CN103690755B (zh) | 一种治带片的应用 | |
CN103655865B (zh) | 一种白蒲黄片的应用及制备方法 | |
CN105194002A (zh) | 一种含紫锥菊的植物组合物提取方法和应用 | |
CN103610857B (zh) | 一种归红跌打丸的制备方法及应用 | |
CN103720775B (zh) | 一种活血丸的制备方法及应用 | |
CN105055587A (zh) | 一种含银杏叶的植物组合物提取方法和应用 | |
CN105106570A (zh) | 一种含大蒜的植物组合物提取方法和应用 | |
CN105250373A (zh) | 一种含丹参的植物组合物提取方法和应用 | |
CN102824380B (zh) | 莲芝消炎滴丸在制备抑制ht1080细胞增殖药物中的应用 | |
CN103656181B (zh) | 一种妇康宁片的应用及制备方法 | |
CN103705695B (zh) | 一种中成药的应用及制备方法 | |
CN105381056A (zh) | 一种含益母草的植物组合物提取方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Lei Inventor after: Sun Lei Inventor after: Wang Fang Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151228 Address after: 266300, No. 29, Xuzhou Road, Jiaozhou, Shandong, Qingdao Applicant after: Wang Lei Address before: Gu Tan Road Economic Development Zone in Gaochun County of Nanjing City, Jiangsu province 211300 branch No. 3 Building Room 607 Applicant before: Nanjing Zhengliang Medical Technology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200428 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 266300, No. 29, Xuzhou Road, Jiaozhou, Shandong, Qingdao Patentee before: Wang Lei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200605 Address after: No.20, group 12, Hongyuan village, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Xi Jinming Address before: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |